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Dynamic changes in body weight have long been recognized as important indicators of risk for debilitating diseases. While
weight loss or impaired growth can lead to muscle wastage, as well as to susceptibility to infections and organ dysfunctions, the
development of excess fat predisposes to type 2 diabetes and cardiovascular diseases, with insulin resistance as a central feature
of the disease entities of the metabolic syndrome. Although widely used as the phenotypic expression of adiposity in population
and gene-search studies, body mass index (BMI), that is, weight/height2 (H2), which was developed as an operational definition
for classifying both obesity and malnutrition, has considerable limitations in delineating fat mass (FM) from fat-free mass (FFM),
in particular at the individual level. After an examination of these limitations within the constraints of the BMI–FM% relationship,
this paper reviews recent advances in concepts about health risks related to body composition phenotypes, which center upon
(i) the partitioning of BMI into an FM index (FM/H2) and an FFM index (FFM/H2), (ii) the partitioning of FFM into organ mass
and skeletal muscle mass, (iii) the anatomical partitioning of FM into hazardous fat and protective fat and (iv) the interplay
between adipose tissue expandability and ectopic fat deposition within or around organs/tissues that constitute the lean body
mass. These concepts about body composition phenotypes and health risks are reviewed in the light of race/ethnic variability in
metabolic susceptibility to obesity and the metabolic syndrome.
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Introduction
Although malnutrition and obesity, as defined by body mass
index (BMI), impose a substantial toll on life expectancy, it is
clear that BMI has considerable limitations in the assessment
of body composition and lack sensitivity for assessing disease
risks, particularly in people who have normal or mildly
elevated body weight. After an examination of these
limitations within the constraints of the relationship
between BMI and % body fat, this paper reviews recent
advances in concepts about health risks related to body
composition phenotypes that, as depicted in Figure 1, center
on (i) the partitioning of BMI into a fat mass (FM) index (FM/
H2) and a fat-free-mass (FFM) index (FFM/H2), (ii) the
partitioning of FFM into organ mass and skeletal muscle
mass, (iii) the partitioning of FM into hazardous fat and
protective fat and (iv) the interplay between adipose tissue
expandability and ectopic fat deposition within or around
organs/tissues that constitute the lean body mass. These
concepts about body composition phenotypes and health
risks are reviewed in the light of race/ethnic variability in
metabolic susceptibility to obesity and the metabolic
syndrome.
The history of BMI: an operational definition for
obesity and malnutrition
Since the early 1970s, considerable effort has been made by
international health organizations to design, perfect and
implement nutritional surveillance pertaining to ‘chronic
energy deficiency’ (CED), a term for which there was a lack
of consensus about its meaning but which was used to
indicate malnutrition resulting from inadequate household
food supply. As CED was a loosely defined term for a major
nutritional health hazard, an International Dietary Energy
Consultancy Group (IDECG) task force was appointed in the
late 1980s to come out with an operational definition for
specifying the degree of CED in adults.1 It proposed the use
of BMI, the ratio of body weight to height2, which Keys
et al.,2 while evaluating weight–height indexes as measures
Correspondence: Dr AG Dulloo, Division of Physiology, Department of
Medicine, University of Fribourg, Rue du Muse´e 5, Fribourg CH-1700,
Switzerland.
E-mail: abdul.dulloo@unifr.ch
1
Published in 	


	
which should be cited to refer to this work.
ht
tp
://
do
c.
re
ro
.c
h
of adiposity a decade earlier, found to have the highest
correlations with % body fat as measured by skinfold and
hydrodensitometry. Provisional cutoff points for low BMI
were developed to define grades of CED in the same way as
Garrow3 was proposing higher levels of BMI to define grades
of obesity, with different categories.
The simplicity of this operational definition for classifying
both malnutrition and obesity is encapsulated by the late
Norgan4 as follows: ‘Body weight and height are two simple
anthropometric measurements fundamental to the physical
description of an individual or population. Both measure-
ments possess the virtues of being precise (highly repeata-
ble), accurate (close to the true value) and valid (representing
what they are thought to represent). By themselves, they
provide useful information on the mass and size of the
human body, particularly the adiposity of the body. As
different levels of fatness and energy stores in an individual
or population are associated with different levels of morbid-
ity and mortality, there is a need for a simple, non-invasive
method for assessing fatness.’ This need has been the
impetus behind the use of BMI to monitor malnutrition
and obesity, which, over the past few decades, have formed
the basis of the World Health Organization BMI cutoff
points5 for classifying underweight, healthy weight, over-
weight and obese (Figure 2).
From the standpoint of cutoff points for underweight or
‘thinness’ thought to reflect different degrees of malnutri-
tion, it was recognized that a measure of body fat is not so
much that it provides a better index of energy stores but
simply that the greater the proportion of fat in the body, the
less likely it is for the individual to lose lean tissue,6 a notion
that, as shown in Figure 3, has been validated on data from
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Figure 1 Concepts of body composition phenotypes depicting the
partitioning of body mass index (BMI) into a fat-free-mass index (FFMI) and
a fat mass index (FMI), followed by partitioning of FFMI and FMI into
subcompartments, and their potential impact on heath across race and
ethnicity.
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Figure 2 Classification and cutoff points for overweight and obesity versus thinness and malnutrition, according to the World Health Organization.5 The reference
zone for BMI is wide (18.5–25 kgm2), partly to account for differences in body build. On the obesity side (morbid/massive obesity), there is no further category
defined above a BMI of 40 kgm2, which is less than twice the midrange ‘normal’ BMI. Yet, one of the highest BMI recorded (185 kgm2) is about eight times higher
than the midrange reference BMI value. On the side of malnutrition, the BMI leading to death (about 9–12 kgm2, depending on sex, that is, 26–35 kg for 1.7m
height) is only half the midrange reference value! Note that the categories of BMI below 18.5 are very narrow, hence very sensitive to a few kg difference in body
weight (1–1.5 units delta) as compared with those defining excess weight or obesity (5 units delta). At very low BMI values, a decrease in BMI primarily reflects the
mobilization of FFM (which is critical for life), as at these levels, the fat mass is already very low. In contrast, at high BMI, the gain in body weight is primarily
composed of adipose tissue, with little FFM added to the body. CED, chronic energy deficiency; PEM, protein-energy malnutrition.
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the Minnesota Experiment7 on dynamic changes in body
composition in normal-weight men undergoing experimen-
tal starvation.8 As pointed out by Hull et al.,9 in hospitalized
individuals, recognition of malnutrition inferred from BMI is
particularly important because nutritional status is related to
longevity and mortality, influences the course of a disease
and optimal treatment and affects the length of hospital
stay. By comparing values of an individual patient with
national norms, the health professional is able to assign a
level of fatness, determine the level of risk for chronic disease
and estimate mortality risk.
From the standpoint of BMI cutoff points for overweight
and obesity, the greater the proportion of fat in the body the
greater the risk for chronic diseases, in particular type 2
diabetes and cardiovascular diseases. Of the many epidemio-
logical studies that have addressed the complex association
between obesity, chronic diseases and survival, the most
recent analysis of data from some 900000 participants in 57
prospective studies on four continents confirms that obesity,
as measured by BMI, is associated with increased total
mortality in both men and women and in all age strata
from 35 to 89 years.10 This epic study also confirms the
results of smaller studies, indicating that obesity shortens
lifespan and that increased mortality due to high BMI is
mainly from specific causes, such as ischemic heart disease,
stroke, diabetes and liver disease. It also shows that people
with BMI in the low–normal range (18.5–22.5 kgm2) have
an increased risk of death (mainly due to respiratory
diseases), compared with the risk in individuals with BMI
between 27.5 and 30kgm2, and hence underscores the
protective role of fat stores during exposure to acute insults
or to chronic wasting, resources that people with low–
normal BMI do not have.
BMI as a surrogate measure of body composition
Despite the fact that numerous techniques are now available
for estimating body composition, there is no single gold
standard for measurements in vivo. All methods incorporate
assumptions that do not apply in all individuals, and the
more accurate models are derived by a combination of
measurements, thereby reducing the importance of each
assumption. However, because of their costs in terms of time
and money, these methods are not practical in large
epidemiological studies and for routine clinical use.11 In
these situations, BMI is often used and assumed to represent
the degree of fatness. Although it remains the most widely
applied phenotypic expression of human adiposity, its close
scrutiny over the years has led to the consistent observation
that correlations with adult adiposity are generally modest,
and that other factors, such as age, race, shape and physical
activity levels, confound the BMI–adiposity relationship.
These confounding effects are elaborated below.
BMI and muscle mass
BMI does not distinguish between FM and lean (non-fat)
mass or FFM, and the latter can also vary considerably
between individuals of the same height. For example, body
builders and competition athletes in other power and
strength sports (boxing, shot put, wrestling and culturism)
have a low proportion of fat in the body, but their BMI is
often in the overweight/obese range because of their large
lean (muscle) mass. Conversely, a deficit of BMI may be due
to a deficit in FFM (sarcopenia) or due to a mobilization of
adipose tissue or both combined. Furthermore, data suggest
different health effects of FM and FFM. When only BMI is
used as a criterion of nutritional status, these divergent
relationships cannot be distinguished. For example, in
elderly individuals not classified as obese, involuntary
weight loss as FM was associated with decreased mortality,
whereas weight loss as FFM was associated with increased
mortality.12 By applying advanced magnetic resonance
imaging techniques, Heymsfield et al.13 have recently shown
that, after controlling first for adiposity, skeletal muscle mass
is also a significant and independent determinant of BMI in a
population-based sample. Variation in muscularity repre-
sents a confounding factor and thus provides a mechanistic
basis for the previously observed nonspecificity of BMI as a
phenotypic expression of adiposity. These quantitative
observations have important implications when choosing
adiposity measures in population and gene-search studies.
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Figure 3 Exponential relationship between the fraction of energy lost as
protein during semistarvation (Pratio) and the initial percentage body fat
(%FAT0) in healthy men (n¼ 32) participating in the classic Minnesota
experiment.7 The data for initial body fat (range 6–25%) follow a normal
distribution, with an almost threefold variability between the 10th percentile
value (7.4%) and the 90th percentile value (20.5%), and with the 50th
percentile (median) value being 13.7%. Comparison is made with the best fit
of a model prediction of the partitioning characteristic (– – –, r2¼0.73) as a
function of %FAT0 with the actual exponential relationship (FF, r2¼0.71)
observed between data for Pratio of the Minnesota men and %FAT0. Note that
both curves are almost superimposable when %FAT0 is greater than 5%
(the lower limit of percentage body fat in a healthy population), and that
both the predicted and actual relationships yield similar values for r2, that is,
0.7. Adapted from the study by Dulloo and Jacquet.8
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BMI–FM% relationship: linear or curvilinear?
There has been some controversy as to whether the relation-
ship between BMI and % body fat (FM%) is linear or
curvilinear. Webster et al.,14 who undertook measurements
of body composition in lean and obese women using the
water dilution technique, argued from an analysis of their
data and from theoretical considerations that the BMI–FM%
relationship was curvilinear (or quadratic), with values
tailing off at an FM% of 55–60% in women. In contrast, a
study from the United States of America15 found that the
relationship was linear rather than quadratic. However, in
this last study, the range of BMI values was limited as
virtually all subjects had a BMI of o35 kgm2. Two more
recent findings addressing this issue on populations in the
United States of America16 and Europe17 are in agreement
with the early demonstration by Webster et al.14 that the
BMI–FM% relationship is curvilinear in both men and
women, as shown in Figure 4. This nonlinear response is
expected from the influence of individuals with BMI much
above 35 kgm2. Note the large scatter of BMI in the BMI
range classified as ‘overweight’: for a given BMI, the range in
body fat can be almost twofold! The explanation for FM%
tailing off at very high BMI remains a matter of conjecture.
Could this effect reside in a disproportionately greater FFM
relative to FM for BMI 435, perhaps resulting from the
gravitational effect of carrying excessive adipose mass (and
hence excess weight) on skeletal muscle mass? It is difficult
to conceive that the composition of net weight added to a
super morbid obese would have less fat (in %) than a less
obese subject gaining a similar amount of weight! Another
explanation would be methodological, as it could result from
technical errors inherent in measuring body composition in
excessively obese people. In general, the amount of variation
in FM% that is explained by BMI when age is accounted for is
o60% in men and women. Thus, the association between
BMI and FM% is not strong, particularly in the desirable BMI
range and when BMI iso25kgm2, as might be expected for
the curvilinear relationship.17 It should be emphasized,
however, that body fat is measured with a much greater
error than body weight and height. Consequently, this
would weaken the relationship between the two variables
and explain why any potential superiority of body composi-
tion measurements over BMI in predicting health risks is
difficult to demonstrate. For example, in an investigation on
a study population with a high prevalence of metabolic
syndrome, Bosy-Westphal et al.18 reported that measurement
of body fat (as FM%) by air displacement plethysmography
has no advantage over BMI and waist circumference in the
prediction of obesity-related metabolic risk factors assessed
as blood triglycerides, cholesterol, uric acid, C-reactive
protein and insulin resistance by the homeostasis model
assessment-insulin resistance model.
BMI–FM% relationship and race/ethnicity
Over the past two decades, it has become clear that the
relationship between BMI and FM% differs among ethnic
groups and populations. Differences in the BMI–FM%
relationship compared with that in Caucasians have repeat-
edly been documented in Asians of many ethnicities
(Chinese, Indians, Indonesians, Malays, Japanese), wherein
FM% in men and women is found to be higher at a given
BMI.19–21 Asian Indians, in particular, consistently exhibit
the greatest deviation from Caucasians with up to 5% higher
body fat at any BMI value, as well as increased risks of type 2
diabetes and cardiovascular diseases at lower BMI. In several
studies, differences in BMI–FM% relationship could be
ascribed to differences in body build and/or frame size. It is
well known that ethnic groups differ in frame size and in
relative leg length (relative sitting height) and that this has
an impact on BMI.4 In addition to differences in trunk-to-
leg-length ratio, slenderness and muscularity may also
contribute to these racial differences in the BMI–FM%
relationship.5,13
On the basis of these findings and the observed differences
in the relation between BMI and disease risk, lower BMI
cutoff points have been advocated to define overweight and
obesity for specific ethnic groups. However, the expert
committee of the World Health Organization has not
redefined the cutoff points for specific Asian populations,22
because available data do not necessarily indicate a clear BMI
cutoff point for all Asian ethnic groups. For example, in
contrast to Chinese adults in Singapore or New York, the
BMI–FM% relationship in Chinese immigrants to Vancouver
did not differ from that of White Canadians, nor did native
Chinese in Beijing differ from Dutch adults.20–22 Further-
more, there are also indications that the BMI–FM% relation-
ship also differs among Caucasian groups.19 These data may
not necessarily be conflicting, as it is possible that the
differences observed between studies result from different
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Figure 4 Nonlinear plot of the relationship between BMI and measured
percentage body fat (FM%) by hydrodensitometry of the men and women
from the Heritage Family Study data. Adapted from Jackson et al.16
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methods of assessing body composition, which often rely on
assumptions that are not validated in the population under
study.
As for comparisons between populations of Caucasians
and those of African descent, no clear differences in the
relation between BMI and FM% have been observed for
African Americans versus Caucasian Americans, nor between
Black and White South Africans.20 By contrast, the BMI–
FM% association was found to vary among populations
whose ancestry originated from West Africa.23 Despite a
similar genetic background, African Americans had higher
body fat at any given BMI than did Jamaicans, and both had
higher levels than rural Nigerians.
These findings underscore the point that, although it is
tempting to attribute all the differences in this relationship
to factors inherent in the specific populations (genetic
backgrounds influencing body build proportions and there-
by affecting relative BMI), it is possible that environmental
factors such as variation in diet and activity also contribute
to the observed differences. As a population migrates to new
environments and changes with regard to weight and height
over generations, the relationship between BMI and FM%
may also be affected.20 It is unclear how these potential
generational changes and ethnic-specific differences in the
BMI–%FM relationship influence risk of chronic diseases,
particularly type 2 diabetes. As Deurenberg24 has argued,
redefining (different) cutoff points for different ethnic
groups should be based not only on the relationship between
BMI and FM% but also on morbidity and mortality risks in
relation to BMI. For the body composition component, this
calls for international multicenter studies in which the
method of measuring FM% is highly standardized and free of
assumptions. Heavy water (Deuterium) dilution might be the
most feasible alternative, as the method is easy to standar-
dize, application is relatively easy even in field situations and
samples can be sent for analyses to a specialized laboratory or
analyzed locally using the cheaper benchtop Fourier trans-
formed infrared approach, which is therefore more accessible
in many developing countries than a mass spectrometer.
BMI partitioning: fat mass index and
fat-free-mass index
An issue that has plagued nutritionists and body composi-
tion specialists is the expression of body composition data
when interindividual comparisons are made: should com-
parisons be made in absolute value (kg) compared with
relative value (% of body weight) or a normalized value for
‘size’ (that is, by height or height2 such as in the BMI
concept)? As FFM is related to height, it seems inappropriate,
as is sometimes used in clinical practice, to assign, for any
individual, a cutoff point of FFM in absolute value (kg) below
which FFM is judged as ‘low’. For example, a short individual
would be penalized, as his absolute FFM is expected to be
lower than that of a tall individual. Indeed, a healthy and
well-nourished young man would have an FFM expressed in
absolute terms in virtually the same way as that of a similarly
aged but taller individual suffering frommild protein–energy
malnutrition. Similarly, the use of FM% to describe the status
of the body’s fat stores can be misleading in cases of
malnutrition or in disease states such as AIDS, in which
individuals may be characterized by a normal %fat but suffer
from wasting or reduced FFM. To overcome some of the
pitfalls associated with merely expressing FM or FFM in
absolute terms or as % of body weight, VanItallie et al.25 have
proposed the use of an FFM index (FFMI) and an FM index
(FMI). This concept merits a reappraisal and appears to be of
interest in the classification of underweight/‘under-lean’
patients and overweight/‘over-fat’ patients.
Calculation of FFM and FM indices: a simple partitioning
of BMI
The FFM and FM indices are equivalent concepts to the BMI
(as the denominator is the same), and result from the
partitioning of BMI into two subcomponents using body
composition, namely,
BMI ðkg/m2Þ ¼ FFMI ðkg/m2Þ þ FMI ðkg/m2Þ;
hence FFMI ¼ ðBMI FMIÞ and FMI ¼ ðBMI FFMIÞ
Thus, FFMI and FMI use similar ratios for their calculation as
does BMI, the only difference being that the numerator is
composed of FFM or FM rather than body weight also in kg.
Considering the equation above, an increase (or a decrease)
in BMI could be accounted for by an increase (or a decrease)
in either subcomponents (FFMI or FMI) or in both compo-
nents. Note that, for a given BMI, if FFMI increases then FMI
should mathematically decrease, as, at a constant BMI, there
is a perfect inverse relationship between the two values.
FFM versus FM indexes: usefulness in obesity and leanness
By determining these indices, quantification of the amount
of excess (or deficit) FFM and FM can be calculated for each
individual. Thus, the calculation of FFMI will allow a
clinician to identify a malnourished individual, whereas
interpretation of BMI and FM% may fail to detect the
presence of protein–energy malnutrition. Although BMI is a
useful tool to compare body weights in individuals who
differ in height, FFMI and FMI are useful for the comparison
of body composition in individuals who differ in height.
Some other potential advantages are listed below:
(i) The advantage of the combined use of these indexes is
that one can judge whether the deficit or excess of body
weight is selectively due to a change in FFM, FM or both
combined. For example, an individual of 1.85m and
100kg, and hence having a BMI of 29.2 kgm2, would
be judged as largely overweight and even borderline
obese. This would be true if his FMI is higher than the
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reference values and conversely if his FFMI is not
simultaneously elevated.
(ii) Another advantage of FMI, as compared with the BMI
concept, is that it amplifies the relative effect of aging
on body fat. Expression of a change in relative body FM
(%) alone fails to allow an appropriate comparison
among subjects of different sizes. The high sensitivity of
FMI (or conversely of FFMI) to a slight change in body
fat stores (or conversely lean tissue mass), compared
with the use of BMI or FM% as factors, makes it an index
of potential interest for assessing static and dynamic
nutritional status and energy reserve end points.
(iii) The use of FFMI may also provide insight into
sarcopenic obesity, a major public health concern in
the elderly population when a stable body weight and
BMI may be masking an increase in total body fat and a
decrease in FFM. Baumgartner et al.26 defined sarcopenic
obesity, associated with greater disability in elderly
subjects, as a relative FFM lower than 73% (that is,
a relative body fat 427%) in men and an FFM o62%
(that is, a body fat438%) in women. Sarcopenic obesity
could well be defined on the basis of FFMI and FMI, that
is, a low FFMI associated with high FMI, which may
prove helpful for monitoring the development and
progression of sarcopenia, leading to efforts to prevent
disability and for the evaluation of rehabilitation
programs following a fall or fracture. However, the
diagnosis of sarcopenic obesity based on these two
indices remains to be further defined.
(iv) The concept of FFMI could also be useful for calculating
the relative muscle hypertrophy in bodybuilding and
other sports, in which heavy muscular body build needs
to be measured quantitatively to exclude false diagnosis
of excess body fat based on single BMI measurements.
Overall, when combining FFMI with FMI, four extreme
situations, shown in Figure 5, can be observed:
(a) low FFMI versus high FMI judged as sarcopenic obesity at
different levels of BMI;
(b) low FFMI versus low FMI corresponding to CED (that is,
low BMI);
(c) high FFMI versus low FMI as evidence of muscle
hypertrophy (excess BMI without obesity);
(d) high FFMI versus high FMI, which suggests combined
excess FFM and FM (such as in a SUMO somatotype with
obese BMI).
FFMI in different race/ethnic groups
The FFMI and FMI percentiles have been developed in
European Caucasians aged 18–98 years.27 Although no
reference data exist for the FFMI in a diverse cohort, data
have been published on how total body potassium differs by
race.28 Total body potassium, which is intracellular and
found in lean tissues such as skeletal muscle, is used as a
proxy to provide an estimate of FFM. For both genders, total
body potassium values were highest in African Americans
and the least in Asians.28 In a recent study, using DEXA for
assessing body composition, Hull et al.,9 investigating
whether FFMI differs in 1339 healthy adults (age 18–110
years) of different races and ethnicity (Caucasian vs African
American, Hispanic and Asian), found that FFMI differed
among the four ethnic groups for both genders (males4
females), with FFMI greatest in African Americans and the
least in Asians. These highlight racial disparities in body
composition and suggest that identification of individuals
by race will show greater susceptibility for disease related to
loss of FFM. Further metabolic studies are needed to identify
or clarify the interracial differences in FFMI in relation to
health risk.
FFMI across adult age
The study by Hull et al.9 also reported a curvilinear relation-
ship between age and FFMI for both genders, and that there
was a gender difference in the rate of change in FFMI with
age. Declines in FFMI were found at an earlier age in male
subjects, whereas decline in female subjects occurred in the
late 40s. Schutz et al.27 found that, in women, FFMI was 20%
(v) Low
FMI N
High
FFMI
(v) Low High
Muscle Hypertrophy
(Body building)
Chronic
Energy Deficiency
(Anorexia, PEM) 
SUMOSarcopenic Obese
Sarcopenic Elderly
Low
% Fat N
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Low High
SUMOSarcopenic Elderly
Sarcopenic Obese
Chronic Energy
Deficiency
(Anorexia, PEM)X
X
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(Body building)
N
N
% Fat-free mass
Figure 5 (a) Combinations in a latin square of the two components, FFMI
(kgm2) versus FMI (kgm2). When these indexes are used in combination,
the different conditions shown can be easily separated, defined and
diagnosed. (b) Combinations in a latin square of the two components, %
fat-free mass versus % fat mass. Note that both are mathematically inversely
interrelated (x, impossible values). When the absolute mass of each
subcomponent of the body is disregarded by presenting values in %, there
is a cluster of conditions that render the interpretation of body composition
very difficult. N, normal; PEM, protein–energy malnutrition; v, very.
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lower than in men, but this difference did not fully persist
with aging. It is unknown how the gender differences in the
rate of decline in FFMI levels or the time point in the lifespan
when the decline commences, predicts or relates to health
outcomes or if the later decline in FFMI may help explain the
greater longevity in female versus male subjects.
FFMI and FMI in children
In children, the calculation of FFMI and FMI relies on
population growth reference standards expressed as BMI
combined with concomitant body composition data mea-
sured with appropriate methodology in the same popula-
tion. The pattern is highly dynamic as, at a certain age
category (puberty), BMI increases in both gender, whereas %
body fat decreases or stagnates in boys and increases in girls.
Special charts that facilitate the interpretation of FFMI and
FMI in children have been suggested.29 The use of this index,
which is promising but requires a valid assessment of body
composition by the pediatrician, is increasingly under
evaluation.30–32
Perspective
Reference intervals of FMI versus FFMI, for adults, children
and teenagers, can be used as indicative values for the
evaluation of nutritional status (degree of overnutrition or
undernutrition) of apparently healthy subjects. It can also
provide complementary information to the classical expres-
sion of body composition reference values. FMI is able to
identify individuals with elevated BMI but without excess
FM. Conversely, FMI can identify subjects with ‘normal’ BMI
but who are at potential risk because of elevated FM. The
shortcomings and advantages of these two indices, the
importance of which has been hampered by its apparent
complexity, are outlined in Table 1. The importance of high
FMI and low FFMI needs to be further explored in a dynamic
way (in particular, in children), on the basis of longitudinal
studies in order to determine at what levels these two
variables, when used in combination, yield the lowest
disability, low-risk factors and prolonged longevity.
Partitioning FFM into muscle mass and organ mass
FFM is the principal contributor to resting energy expendi-
ture (REE), and total body FFM is commonly used as a proxy
for metabolically active tissue for normalizing (adjusting)
interindividual differences or within-individual changes in
energy expenditure. It is, however, a heterogeneous com-
partment containing organ/tissues that possess a wide range
of specific metabolic rates.33 Skeletal muscle constitutes
40–50% of total body weight and accounts for only 20–30%
of REE. This contrasts with the brain, liver, heart and kidneys,
which collectively contribute to o6% of total body weight,
but account for about 60–70% of REE in adults (Figure 6).
Consequently, relatively subtle differences or changes in
Table 1 Advantages and shortcomings of FFMI and FMI
Advantages Shortcomings
FMI is relatively independent of FFM Need accurate
body composition
Calculation is as simple as BMI Affected by body build
In the dynamic change of BC (e.g., puberty),
differentiate between gain in fat versus FFM
Ethnicity factor
Independent of age in adults (unlike BMI) Body fat distribution?
Height squared (denominator) eliminates the
association of the index with the numerator
Adequate for
stunting men?
Abbreviations: BMI, body mass index; FFMI, fat-free-mass index; FMI, fat mass
index; BC, body composition.
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Figure 6 Contribution of organ/tissues to the basal metabolic rate (BMR) of a non-obese man; adapted from Elia.33 Note that organs contribute too6% of body
weight but that their contribution to basal metabolic rate (BMR) is disproportionately high (450% BMR).
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organ masses and/or organ activity can have a significant
impact on interindividual variability in energy expenditure,
and may hence have relevance for metabolic predisposi-
tion to leanness or fatness. Over the past few years, the
application of imaging techniques, such as computed
tomography and magnetic resonance imaging, in quantifica-
tion of the size of these tissues and organs in vivo has shown
the potential of such an approach toward a better under-
standing of the contribution of these FFM subcomponents to
the decline in REE with age34 and in racial differences in
REE.35 It has been known for some time that, in comparison
with White Americans, African Americans have significantly
greater bone mass and skeletal muscle mass36 and lower or
similar FM15 but a different fat distribution pattern.15 Using
magnetic resonance imaging, Gallagher et al.35 have ex-
tended this list of body composition differences to include
lower masses of the liver, kidney, spleen, heart and brain.
The implication, therefore, is that African Americans may
have a significantly smaller proportion of FFM with high
metabolic rate organs than do Whites, which helps explain
many previous reports of lower REE adjusted for FFM
in African Americans than in Whites.37 In the study by
Gallagher et al.,35 B50% of the observed remaining differ-
ence in REE between African American and White men
and women, after adjusting for age, fat and FFM, could
be explained by differences in the mass of these organs.
Because REE is B65% of daily energy expenditure, the daily
differences in REE observed in these studies (100–150 kcal),
if not compensated for by a lower intake, may over a
prolonged period of time be a contributing factor to the
greater incidence of obesity in African-American than in
White women. The mass of high metabolic rate organs and
tissues is therefore a body composition phenotype that
should be considered in future studies on interindividual
variability in REE and in the assessment of metabolic
susceptibility to obesity across various racial ethnic groups.
However, tracking these organs requires expensive advanced
body composition techniques.
Partitioning FM into hazardous fat and
protective fat
During the past 60 years, research toward understanding how
excess fat predisposes to chronic diseases has been dominated
by concepts centered on the specific locations at which fat
accumulates in the body. In the 1950s, Vague38 proposed that
excess fat stored in the trunk or android obesity could be
metabolically more damaging than fat stored in the limbs
(or gynoid obesity). Since then, a large number of cross-
sectional and prospective studies have confirmed that indivi-
duals who have an upper body rather than a lower body
distribution of fat have an elevated risk for type 2 diabetes
and cardiovascular diseases.39 These findings have served as
the basis for classifying patients by measurement of waist
circumference or waist-to-hip ratio, and for the recognition
that abdominal (or central) obesity is a cardinal feature of
the metabolic syndrome, with insulin resistance as a key link
between abdominal fat and risks for chronic diseases.
Upper body fat
Whether specific anatomical compartments in the abdom-
inal region confer greater risk for insulin resistance and its
complications is, however, controversial. Many studies do in
fact support the concept of a specific role for intraabdominal
fat accumulation or visceral obesity in the link between
abdominal obesity and insulin resistance. In particular,
removal of visceral adipose tissue (VAT) by omentectomy
results in decreased glucose and insulin levels in humans,40
whereas removal of subcutaneous adipose tissue (SAT) by
liposuction does not always result in an improvement in
glucose and lipid metabolism.41,42 The causative mechanism
is attributed to the release of free fatty acids from VAT,
which, by draining into the portal vein, exerts adverse effects
on hepatic metabolism. However, there is no clear proof of
such a causal link between VAT and insulin resistance. Both
are in fact common correlates of abdominal SAT accumula-
tion, which, on the basis of its considerably larger mass than
VAT, could have a greater potential to contribute to insulin
resistance through the release of free fatty acids into the
systemic circulation.43 Goodpaster et al.44 showed that SAT
was positively associated with insulin resistance in White
Caucasians after adjusting for VAT. In addition, it has been
reported that posterior or deep subcutaneous adipose tissue
(DSAT) is more importantly associated with peripheral and
hepatic insulin sensitivity than anterior or superficial
subcutaneous adipose tissue (SSAT) in White Caucasian
men,45 and in other ethnic groups such as African Amer-
icans46 and South Indians.47 In addition, at any given FFM,
men had more DSAT and less SSAT than women, regardless
of ethnicity, a sexual dimorphism that mimics the pattern
observed for VAT in relation to FM48,49 and could also
provide insights into the cardioprotective role of the SAT
depot in women.50 It would seem therefore that abdominal
SAT can no longer be regarded as one single entity, but that
there are two anatomically and functionally distinct com-
partments: the SSAT and the DSAT compartments, which are
separated by a fascial plane and can be recognized by
computed tomography scan or magnetic resonance imaging.
There seems to be a gradient toward less organization and
more vascularization of the adipose tissue depots proceeding
from the outermost compartment, SSAT to DSAT and then to
VAT;51 this gradient in abdominal adipose tissue could be of
potential importance in assessing the risk for the metabolic
syndrome.
Ectopic fat
In humans and in most animal models, the development of
obesity leads not only to increased fat depots in classical
adipose tissue locations, such as in the SAT and VAT
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compartments, but also to significant lipid deposits within
and around other tissues and organs.52 This phenomenon of
ectopic fat deposition can impair tissue and organ function
in two possible ways. First, lipid accumulation can occur in
non-adipose cells and may lead to cell dysfunction or cell
death, a phenomenon known as lipotoxicity. Intracellular
lipid accumulations in endocrine pancreas, liver and skeletal
muscle cells have all been described and contribute to the
pathogenesis of impaired insulin secretion and insulin
resistance.53 Second, a substantial increase in the size of fat
pads around key organs, although constituting a physical
protection against external shock, could modify organ
function either by simple physical compression or because
peri-organ fat cells may secrete various locally functioning
substances.52 Increased epicardial fat pads associated with
intramyocardial lipid deposition may lead to both systolic
and diastolic dysfunctions, whereas accumulation of fat
around blood vessels (perivascular fat) may affect vascular
function in a paracrine manner, as perivascular fat cells
secrete vascular relaxing factors, proatherogenic cytokines
and smooth muscle cell growth factors.54,55 High amounts of
perivascular fat could also mechanically contribute to the
increased vascular stiffness observed in obesity, whereas
accumulation of fat within the renal sinus associated with
the increased intraabdominal pressure of visceral obesity
may compress the renal papilla, the renal vein and
lymphatics vessels, altering intrarenal physical forces that
favor sodium reabsorption and arterial hypertension.52
Finally, the accumulation of adipose tissue surrounding
skeletal muscle bundles, that is, intermuscular adipose tissue
(IMAT), albeit in the thigh region, also has a strong
association with insulin resistance.56,57 IMAT may affect
peripheral insulin dynamics by impairing muscle blood flow,
reducing insulin diffusion capacity, increasing local concen-
trations of fatty acids or enhancing rates of lipolysis within
skeletal muscle.56 Taken together, ectopic fat storage in the
lean tissue compartment may impair their functions, con-
tributing to the increased prevalence of type 2 diabetes and
cardiovascular diseases in obese subjects.
Lower body fat
In contrast to upper body obesity, wherein expansion of the
abdominal DSAT and VAT depots has been repeatedly linked
to an increased risk of dyslipidemia, dysglycemia and
vascular disease, an enlarged gluteofemoral adipose tissue
mass (as measured by thigh or hip circumference or leg
adipose tissue mass) is associated with a favorable lipid and
glucose profile, as well as with a decrease in cardiovascular
and metabolic risk.58 This fat depot is viewed as a protective
‘metabolic sink’ functioning as a buffer against the post-
prandial surge in circulatory fatty acids (fatty acid trapping),
and hence protects other tissues from lipid overflow
associated with ectopic lipotoxicity.59 Indeed, femoral fat
accumulation that is typical of female fat distribution
pattern is associated with an increase in adipose tissue
lipoprotein lipase activity, a key enzyme controlling the
entry of fatty acids from the circulation into adipose tissue,
whereas the activity of hormone-sensitive lipase, a key
enzyme in lipolysis, is lower in the gluteal than in the
abdominal fat depot.58 Furthermore, the low amounts of
gluteofemoral fat observed in pathogenic states, such as in
partial lipodystrophy or in Cushing’s syndrome, are asso-
ciated with increased metabolic and cardiovascular risks.58
This underscores the protective properties of gluteofemoral
adipose tissue by the long-term entrapment of excess fatty
acids, thus protecting from the adverse effects associated
with ectopic fat deposition. Gluteofemoral adipose tissue
could also contribute to a more protective adipokine profile
by secreting more beneficial adipokines (leptin and adipo-
nectin) and less proinflammatory cytokines compared with
abdominal fat.
Adipose tissue expandability
During the development of obesity, adipose tissue expands
by increasing the volume of preexisting adipocytes (adipose
hypertrophy), by generating new small adipocytes through
adipocyte proliferation/differentiation (adipose hyperplasia),
or by both. A prevailing concept of the late twentieth
century, namely, that preventing adipocyte differentiation
might serve as a target for obesity, was strongly rebutted by
Danforth,60 who argued that ‘Prevention of adipocyte
differentiation is destined to exchange obesity for diabetes’.
He put forward the hypothesis that type 2 diabetes is the
result of the inability of the adipose organ to expand to
accommodate excess energy, and that type 2 diabetes in the
centrally obese individual, in spite of their unlikely pheno-
type, is a form of lipodystrophy. Since then, the utilization of
both transgenic and knockout murine models has provided
strong support for a central role for adipose tissue expand-
ability in the mechanisms by which both adipose and non-
adipose tissues could predispose to ectopic fat storage and
the metabolic syndrome. According to Virtue and Vidal-
Puig,61 all individuals possess a maximum capacity for
adipose expansion, which is determined by both genetic
and environmental factors. Once the adipose tissue expan-
sion limit is reached, adipose tissue ceases to store energy
efficiently, and lipids begin to accumulate in other tissues,
with such ectopic lipid accumulation in non-adipocyte cells
resulting in lipotoxic insults that include insulin resistance,
tissue damage and inflammation. Indeed, exposure to free
fatty acid has been shown to activate inflammatory signal-
ing, in particular the protein kinases JNK1 and IKK-b, in
several cell types, including adipocytes, hepatocytes, myo-
cytes, pancreatic islet and macrophages.62 At the same time,
hypertrophic adipocytes undergo necrotic cell death, and
leukocytes infiltrate into the saturated adipose tissue. There-
fore, obesity is associated with a chronic inflammatory state,
generally referred to as ‘metabolic inflammation’. It was
indeed proposed that in the link between positive energy
balance and metabolic syndrome, the critical factor that
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triggers metabolic inflammation is not adiposity per se but a
saturation of the lipid storage capacity of adipocytes.62
Consistent with this contention are findings that obese
subjects with few large adipocytes are more glucose intoler-
ant and hyperinsulinemic than those having the same
degree of obesity and many small fat cells.63–65 In long-
itudinal studies, enlarged subcutaneous abdominal adipo-
cyte size has been shown to be an independent predictor of
type 2 diabetes, including in Pima Indians in Arizona66 and
more recently in a population-based Swedish (Caucasian)
cohort.67 Furthermore, gene expression profiling of human
adipocytes of different sizes from the same adipose
tissue sample has identified genes with markedly higher
expression in large than in small adipocytes: the majority
were immune related, with importance for cell structure, or
with unknown function.68 As adipocyte hypertrophy may
impair adipose tissue function by inducing local inflamma-
tion, mechanical stress and altered metabolism, these genes
may provide links between hypertrophic obesity and meta-
bolic disorders.
Hypertrophic versus hyperplastic adiposity phenotypes
Thus, the risk for metabolic complications is increased not
only by the amount and localization of adipose tissue but
also by the size of adipocytes within the adipose tissue. Sex
differences in body fat distribution and adipocyte metabo-
lism suggest that the storage capacity and propensity for fat
cell hypertrophy or fat cell hyperplasia may be regulated in a
depot-specific manner, and that obese women are prone to
accumulate fat in SAT rather than in VAT. In a study
examining omental and subcutaneous fat depot in French
obese women undergoing abdominal hysterectomies,69
hyperplasia was indeed found to predominate in the SAT
depot, whereas fat cell hypertrophy was observed both in
omental VAT and SAT compartments. A higher storage
capacity of the SAT compartment in women compared with
men could theoretically prevent fat accumulation in the VAT
compartment, and explain their lower prevalence of meta-
bolic disturbances. For any adipose tissue depot, however,
there is a large interindividual variation in adipocyte size
among lean and obese individuals,66,70 such that lean
individuals can have larger adipocytes than obese indivi-
duals and vice versa. The mechanisms responsible for the
development of these different forms of adipose morphology
are largely unknown. However, in recent years, measurement
of adipocyte turnover by analyzing the incorporation of
atmospheric 14C (derived from 1950s nuclear bomb tests) in
genomic DNA has indicated that the turnover rate of
adipocytes is high at all adult ages and across all BMI
levels,71 with approximately one-tenth of the total adipocyte
pool being renewed every year by ongoing adipogenesis and
adipocyte death. In a follow-up study,72 a low adipocyte
turnover could be associated with adipose hypertrophy,
which is linked to low insulin sensitivity and high circulat-
ing insulin levels. Conversely, a high adipocyte turnover
could be associated with the more benign adipose hyperpla-
sia. These findings suggest that, in hypertrophic state, the
body produces few adipocytes over time, requiring existing
adipocytes to accumulate more lipids in comparison with
the hyperplastic state.
Race/ethnicity and FM partitioning
The higher risks for type 2 diabetes and cardiovascular
diseases in people of Aboriginal, Asian or African descents
than in those of European descent have often been
attributed to race–ethnic differences in body fat distribu-
tion.73,74 There have been conflicting findings, however, as
to the role of an enlarged VAT is these race–ethnic
differences, with VAT being reported to be greater75 or no
different76 in South Asians than in Caucasians, or increased
VAT being found in women, but not in men, of Asian origin
compared with Europeans.77 Ethnicity-specific differences in
VAT have also been reported between African Americans and
Europeans, indicating that African-American men have
smaller amounts of VAT, whereas African-American women
have similar or smaller amounts than Europeans for a given
body FM.78–81 However, many of these reports suffer from
small sample size, lack of gender distribution and often fail
to adjust for ethnic differences in total body fat, thereby
introducing an important confounding variable given that
fat-specific depots (VAT and SAT) correlate with total body
fat. Over the past few years, however, a number of
comprehensive studies on race–ethnic differences in fat
distribution and metabolic risks have been conducted in
Europe, Canada and the United States of America. These are
summarized below.
(i) Asians, in whom metabolic complications associated
with obesity (dyslipidemia, insulin resistance and type 2
diabetes) are apparent at lower BMI and waist circum-
ference, show a greater proportion of VAT for a given
total body fat compared with Europeans.82 In particular,
in a study comparing body fat distribution in Chinese,
Indians, Aboriginals and Caucasians of European des-
cent living in Canada, it was shown that for a given
amount of total body fat, the Chinese and South Asian
participants had a greater amount of abdominal adipose
tissue, particularly in the VAT depot than did the
Caucasians.83 In contrast, no differences were observed
between the Canadian Aboriginal and Caucasian parti-
cipants. These data are nonetheless consistent with a
similar study in USA Aboriginals showing no difference
in VAT between Pima Indians and Caucasians matched
for BMI.84
(ii) Other studies have suggested that abdominal (SAT)
depots, which are thicker in adult Asian Indians
compared with European Caucasians, are a more
important predictor of the metabolic syndrome in Asian
Indians than VAT.85,86 In a recent comprehensive
investigation comparing South Asians and Europeans,
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Kohli et al.87 showed that body fat distribution, as
measured by SSAT and DSAT, also differs according to
ethnicity and gender. More importantly, at any given
FFM, South Asians had more DSAT than did Europeans,
regardless of sex, whereas there were no differences
observed in SSAT. Sniderman et al.88 have suggested that
South Asians may have a less-developed SSAT compart-
ment, and therefore, in situations of energy excess,
South Asians would tend to accumulate greater amounts
of adipose tissue in the DSAT compartment, in addition
to VAT, compared with Europeans, and this would
consequently predispose South Asians to developing
early-onset complications that are associated with
obesity. Consistent with these hypotheses are data from
west India, which suggest that Asian Indians have a
tendency for central obesity and have truncal subcuta-
neous adiposity from birth, in spite of having a lower
birth weight compared with British neonates.89
(iii) In the largest study published to date that examined
racial differences in abdominal fat depots, African-
American men and women were found to have lower
amounts of abdominal VAT for a given amount of total
body fat than White Americans, and these differences
increase with the amount of total body fat.90 Further-
more, after adjustment for age, total body FM and other
covariates, abdominal SAT was found to be higher in
African-American men and women compared with
White men and women, respectively. It appears that
the increase in SAT in African Americans is specifically
in SSAT, and not in DSAT, compared with Caucasian or
Hispanic Americans.91
(iv) There is also emerging evidence that African Americans
have less hepatic and intramyocellular lipid levels than
Caucasians or Hispanic Americans.91–93 Furthermore,
intramyocellular lipid has been reported to be a
significant determinant of insulin sensitivity among
healthy, young European Americans, but not among
African-American women.94 At high levels of adiposity,
however, African-American men, though not women,
have greater quantities of total body intermuscular
fat (IMAT) than do Asians or Whites after adjust-
ment for differences in total adiposity and other
covariates.95 To what extent IMAT, which has been
reported to be associated with diminished insulin
sensitivity, contributes to the more diabetogenic profile
and higher cardiovascular risks in African Americans
as compared with Caucasians is currently unknown.
These data do not prove, but suggest that IMAT may
contribute to racial and gender differences in cardio-
vascular risks.
(v) Finally, in a study in young, lean, healthy but sedentary
Asians and Caucasians living in the United States of
America, Asian-Indian men showed a higher prevalence
of insulin resistance, associated with a twofold higher
hepatic lipid content relative to Caucasian men even
after adjustment for insulin sensitivity.96
From an analysis of the above discussions, it is clear that
race/ethnicity is of central importance in determining the
pathways that lead to obesity and metabolic diseases. As
illustrated in Table 2, African-American and South Asian
men are both more susceptible to obesity and metabolic
complications than are White Caucasian men, but they
exhibit marked differences, often in opposite directions, in
several of the phenotypic expressions of body composition
that may be considered hazardous or protective.
Conclusion
Although BMI will remain the best simple measure for
tracking excess and deficit of body weight in various
populations, the time is ripe to go beyond BMI to refine
the assessment of both health risk and health protection
factors (Figure 1). The partitioning of BMI into FMI (FM/H2)
and FFMI (FFM/H2) seems to be useful for characterizing
certain medical conditions (for example, sarcopenia and
sarcopenic obesity), and may be important for defining
health risk factors such as malnutrition. Tracking the
metabolic susceptibility to obesity across various racial/
ethnic groups may benefit from the functional partitioning
of FFM itself into organ mass and skeletal muscle mass, in
addition to the anatomical partitioning of body fat into
Table 2 Body composition phenotyping in men of different race/ethnicity
Asian Indian
vs Caucasians
African Americans
vs Caucasians
Type 2 diabetes and
cardiovascular risks
m m
FFMI k m
Muscle mass k m
Bone mass k m
Organ mass (sum of the liver,
heart, spleen, kidneys, brain)
? k
FMI
Upper body
Superficial SAT m m
Deep SAT m F
VAT m k
Hepatic lipids m k
Lower body
Gluteofemoral
SAT k m
IMAT m m
Intramyocellular lipids
(from leg muscle)
? k
Resting energy expenditure ? k
Abbreviations: FFMI, fat-free-mass index; FMI, fat mass index; IMAT,
intermuscular adipose tissue; SAT, subcutaneous adipose tissue; VAT, visceral
adipose tissue. m¼higher; k¼ lower;F¼no difference; ?¼ unknown.
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hazardous fat and protective fat. Obviously, the budget and
technical expertise needed to assess these subcomponents
will preclude any large-scale study at the epidemiological
level, as well as in fieldwork.
Conflict of interest
The authors declare no conflict of interest.
Acknowledgements
This work was supported by a research grant from the Swiss
National Science Foundation (Grant Number 31003A-
130481).
References
1 James WP, Ferro-Luzzi A, Waterlow JC. Definition of chronic
energy deficiency in adults. Report of a working party of the
International Dietary Energy Consultative Group. Eur J Clin Nutr
1988; 42: 969–981.
2 Keys A, Fidanza F, Karvonen MJ, Kimura N, Taylor HL. Indices of
relative weight and obesity. J Chronic Dis l 972; 25: 329–343.
3 Garrow JS. Treat obesity seriouslyFa clinical manual. Churchill
Livingstone: London, 1981.
4 Norgan NG. Population differences in body composition in
relation to body mass index. Eur J Clin Nutr 1994; 48 (Suppl 3):
S10–S27.
5 World Health Organization. Obesity: preventing and managing
the global epidemic. Report of a WHO Consultation (WHO
Technical Report Series (894) 2000.
6 Elia M. Effect of starvation and very low calorie diets on protein–
energy interrelationships in lean and obese subjects. In: Scrim-
shaw NS, Schurch B (eds). Protein–Energy Interactions. IDECG:
Lausanne, Switzerland, 1991. pp 249–284.
7 Keys A, Brozek J, Henschel A, Mickelson O, Taylor HL. The Biology
of Human Starvation. University of Minnesota Press: Minneapolis,
MN, 1950.
8 Dulloo AG, Jacquet J. The control of partitioning between protein
and fat during human starvation: its internal determinants and
biological significance. Br J Nutr 1999; 82: 339–356.
9 Hull HR, Thornton J, Wang J, Pierson Jr RN, Kaleem Z, Pi-Sunyer
X et al. Fat-free mass index: changes and race/ethnic differences
in adulthood. Int J Obes 2010. (e-pub ahead of print).
10 Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J,
Halsey J, et al., Prospective Studies Collaboration. Body-mass index
and cause-specific mortality in 900000 adults: collaborative analyses
of 57 prospective studies. Lancet 2009; 373: 1083–1096.
11 Snijder MB, van Dam RM, Visser M, Seidell JC. What aspects of
body fat are particularly hazardous and how do we measure
them? Int J Epidemiol 2006; 35: 83–92.
12 Allison DB, Faith MS, Heo M, Kotler DP. Hypothesis concerning
the U-shaped relation between body mass index and mortality.
Am J Epidemiol 1997; 146: 339–349.
13 Heymsfield SB, Scherzer R, Pietrobelli A, Lewis CE, Grunfeld C.
Body mass index as a phenotypic expression of adiposity:
quantitative contribution of muscularity in a population-based
sample. Int J Obes 2009; 33: 1363–1373.
14 Webster JJ, Hesp R, Garrow JS. The composition of excess weight
in obese women estimated by body density, total body water and
total body potassium. Hum Nutr Clin Nutr 1984; 38C: 299–306.
15 Gallagher D, Visser M, Sepu´lveda D, Pierson RN, Harris T,
Heymsfield SB. How useful is body mass index for comparison
of body fatness across age, sex, and ethnic groups? Am J Epidemiol
1996; 143: 228–239.
16 Jackson AS, Stanforth PR, Gagnon J, Rankinen T, Leon AS, Rao DC
et al. The effect of sex, age and race on estimating percentage
body fat from body mass index: the Heritage Family Study. Int J
Obes 2002; 26: 789–796.
17 Meeuwsen S, Horgan GW, Elia M. The relationship between BMI
and percent body fat, measured by bioelectrical impedance, in a
large adult sample is curvilinear and influenced by age and sex.
Clin Nutr 2010; 29: 560–566.
18 Bosy-Westphal A, Geisler C, Onur S, Korth O, Selberg O,
Schrezenmeir J et al. Value of body fat mass vs anthropometric
obesity indices in the assessment of metabolic risk factors. Int J
Obes 2006; 30: 475–483.
19 Deurenberg P, Deurenberg-Yap M, Guricci S. Asians are different
from Caucasians and from each other in their body mass index/
body fat per cent relationship. Obes Rev 2002; 3: 141–146.
20 Luke A. Ethnicity and the BMI-body fat relationship. Br J Nutr
2009; 102: 485–487.
21 Wulan SN, Westerterp KR, Plasqui G. Ethnic differences in body
composition and the associated metabolic profile: a compara-
tive study between Asians and Caucasians. Maturitas 2010; 65:
315–319.
22 WHO Expert Consultation. Appropriate body-mass index for
Asian populations and its implications for policy and interven-
tion strategies. Lancet 2004; 363: 157–163.
23 Luke A, Durazo-Arvizu R, Rotimi C, Prewitt TE, Forrester T, Wilks
R et al. Relation between body mass index and body fat in black
population samples from Nigeria, Jamaica, and the United States.
Am J Epidemiol 1997; 145: 620–628.
24 Deurenberg P. Universal cut-off BMI points for obesity are not
appropriate. Br J Nutr 2001; 85: 135–136.
25 VanItallie TB, Yang MU, Heymsfield SB, Funk RC, Boileau RA.
Height-normalized indices of the body’s fat-free mass and fat
mass: potentially useful indicators of nutritional status. Am J Clin
Nutr 1990; 52: 953–959.
26 Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heyms-
field SB, Ross RR et al. Epidemiology of sarcopenia among the
elderly in New Mexico. Am J Epidemiol 1998; 147: 755–763.
27 Schutz Y, Kyle UU, Pichard C. Fat-free mass index and fat mass
index percentiles in Caucasians aged 18-98 y. Int J Obes 2002; 26:
953–960.
28 He Q, Heo M, Heshka S, Wang J, Pierson Jr RN, Albu J et al. Total
body potassium differs by sex and race across the adult age span.
Am J Clin Nutr 2003; 78: 72–77.
29 Wells JC. A Hattori chart analysis of body mass index in infants
and children. Int J Obes 2000; 24: 325–329.
30 Nakao T, Komiya S. Reference norms for a fat-free mass index and
fat mass index in the Japanese child population. J Physiol
Anthropol Appl Human Sci 2003; 22: 293–298.
31 Demerath EW, Schubert CM, Maynard LM, Sun SS, Chumlea WC,
Pickoff A et al. Do changes in body mass index percentile reflect
changes in body composition in children? Data from the Fels
Longitudinal Study. Pediatrics 2006; 117: 487–495.
32 Eissa MA, Dai S, Mihalopoulos NL, Day RS, Harrist RB, Labarthe
DR. Trajectories of fat mass index, fat free-mass index, and waist
circumference in children: Project HeartBeat. Am J Prev Med 2009;
37 (Suppl 1): S34–S39.
33 Elia M. Organ and tissue contribution to metabolic rate. In:
Kinney JM, Tucker HN (eds). Energy metabolism: tissue determinants
and cellular corollaries. Raven Press Ltd: New York, NY, 1992.
pp 61–79.
34 He Q, Heshka S, Albu J, Boxt L, Krasnow N, Elia M et al. Smaller
organ mass with greater age, except for heart. J Appl Physiol 2009;
106: 1780–1784.
35 Gallagher D, Albu J, He Q, Heshka S, Boxt L, Krasnow N et al.
Small organs with a high metabolic rate explain lower resting
12
ht
tp
://
do
c.
re
ro
.c
h
energy expenditure in African American than in white adults.
Am J Clin Nutr 2006; 83: 1062–1067.
36 Ortiz O, Russell M, Daley TL, Baumgartner RN, Waki M, Lichtman
S et al. Differences in skeletal muscle and bone mineral mass
between black and white females and their relevance to estimates
of body composition. Am J Clin Nutr 1992; 55: 8–13.
37 Weyer C, Snitker S, Bogardus C, Ravussin E. Energy metabolism in
African Americans: potential risk factors for obesity. Am J Clin
Nutr 1999; 70: 13–20.
38 Vague J. The degree of masculine differentiation of obesities: a
factor determining predisposition to diabetes, atherosclerosis,
gout and uric calculous disease. Am J Clin Nutr 1956; 4: 20–34.
39 Despre´s JP, Arsenault BJ, Coˆte´ M, Cartier A, Lemieux I. Abdominal
obesity: the cholesterol of the 21st century? Can J Cardiol 2008;
24 (Suppl D): 7D–12D.
40 Tho¨rne A, Lo¨nnqvist F, Apelman J, Hellers G, Arner P. A pilot
study of long-term effects of a novel obesity treatment:
omentectomy in connection with adjustable gastric banding.
Int J Obes 2002; 26: 193–199.
41 Klein S, Fontana L, Young VL, Coggan AR, Kilo C, Patterson BW
et al. Absence of an effect of liposuction on insulin action and
risk factors for coronary heart disease. N Engl J Med 2004; 350:
2549–2557.
42 Giugliano G, Nicoletti G, Grella E, Giugliano F, Esposito K,
Scuderi N et al. Effect of liposuction on insulin resistance and
vascular inflammatory markers in obese women. Br J Plast Surg
2004; 57: 190–194.
43 Frayn KN. Visceral fat and insulin resistanceFcausative or
correlative. Br J Nutr 2000; 83 (Suppl 1): S71–S77.
44 Goodpaster BH, Thaete FL, Simoneau JA, Kelley DE. Subcuta-
neous abdominal fat and thigh muscle composition predict
insulin sensitivity independently of visceral fat. Diabetes 1997;
46: 1579–1585.
45 Misra A, Garg A, Abate N, Peshock RM, Stray-Gundersen J,
Grundy SM. Relationship of anterior and posterior subcutaneous
abdominal fat to insulin sensitivity in nondiabetic men. Obes Res
1997; 5: 93–99.
46 Tulloch-Reid MK, Hanson RL, Sebring NG, Reynolds JC, Pre-
mkumar A, Genovese DJ et al. Both subcutaneous and visceral
adipose tissue correlate highly with insulin resistance in African
Americans. Obes Res 2004; 12: 1352–1359.
47 Goel K, Misra A, Vikram NK, Poddar P, Gupta N. Subcutaneous
abdominal adipose tissue is associated with the metabolic
syndrome in Asian Indians independent of intra-abdominal and
total body fat. Heart 2010; 96: 579–583.
48 Lear SA, Humphries KH, Kohli S, Chockalingam A, Frohlich JJ,
Birmingham CL. Visceral adipose tissue accumulation differs
according to ethnic background: results of the Multicultural
Community Health Assessment Trial (M-CHAT). Am J Clin Nutr
2007; 86: 353–359.
49 Smith SR, Lovejoy JC, Greenway F, Ryan D, deJonge L, de la
Bretonne J et al. Contributions of total body fat, abdominal
subcutaneous adipose tissue compartments, and visceral adipose
tissue to the metabolic complications of obesity. Metabolism
2001; 50: 425–435.
50 Okura T, Nakata Y, Yamabuki K, Tanaka K. Regional body
composition changes exhibit opposing effects on coronary
heart disease risk factors. Arterioscler Thromb Vasc Biol 2004; 24:
923–929.
51 Markman B, Barton Jr FE. Anatomy of the subcutaneous tissue
of the trunk and lower extremity. Plast Reconstr Surg 1987; 80:
248–254.
52 Montani JP, Carroll JF, Dwyer TM, Antic V, Yang Z, Dulloo AG.
Ectopic fat storage in heart, blood vessels and kidneys in the
pathogenesis of cardiovascular diseases. Int J Obes 2004; 28 (Suppl
4): S58–S65.
53 Unger RH. Weapons of lean body mass destruction: the role of
ectopic lipids in the metabolic syndrome. Endocrinology 2003;
144: 5159–5165.
54 Barandier C, Montani JP, Yang Z. Mature adipocytes and
perivascular adipose tissue stimulate vascular smooth muscle cell
proliferation: effects of aging and obesity. Am J Physiol Heart Circ
Physiol 2005; 289: H1807–H1813.
55 Thalmann S, Meier CA. Local adipose tissue depots as cardiovas-
cular risk factors. Cardiovasc Res 2007; 75: 690–701.
56 Goodpaster BH, Thaete FL, Kelley DE. Thigh adipose tissue
distribution is associated with insulin resistance in obesity and in
type 2 diabetes mellitus. Am J Clin Nutr 2000; 71: 885–892.
57 Gallagher D, Kuznia P, Heshka S, Albu J, Heymsfield SB,
Goodpaster B et al. Adipose tissue in muscle: a novel depot
similar in size to visceral adipose tissue. Am J Clin Nutr 2005; 81:
903–910.
58 Manolopoulos KN, Karpe F, Frayn KN. Gluteofemoral body
fat as a determinant of metabolic health. Int J Obes 2010; 34:
949–959.
59 Frayn KN. Adipose tissue as a buffer for daily lipid flux.
Diabetologia 2002; 45: 1201–1210.
60 Danforth Jr E. Failure of adipocyte differentiation causes type II
diabetes mellitus? Nat Genet 2000; 26: 13.
61 Virtue S, Vidal-Puig A. Adipose tissue expandability, lipotoxicity
and the metabolic syndrome–an allostatic perspective. Biochim
Biophys Acta 2010; 1801: 338–349.
62 Solinas G, Karin M. JNK1 and IKKbeta: molecular links between
obesity and metabolic dysfunction. FASEB J 2010; 24: 2596–2611.
63 Stern JS, Batchelor BR, Hollander N, Cohn CK, Hirsch J. Adipose-
cell size and immunoreactive insulin levels in obese and normal-
weight adults. Lancet 1972; 2: 948–951.
64 Weyer C, Foley JE, Bogardus C, Tataranni PA, Pratley RE. Enlarged
subcutaneous abdominal adipocyte size, but not obesity itself,
predicts type II diabetes independent of insulin resistance.
Diabetologia 2000; 43: 1498–1506.
65 Hirsch J, Knittle JL. Cellularity of obese and nonobese human
adipose tissue. Fed Proc 1970; 29: 1516–1521.
66 Weyer C, Foley JE, Bogardus C, Tataranni PA, Pratley RE. Enlarged
subcutaneous abdominal adipocyte size, but not obesity itself,
predicts type II diabetes independent of insulin resistance.
Diabetologia 2000; 43: 1498–1506.
67 Lonn M, Mehlig K, Bengtsson C, Lissner L. Adipocyte size predicts
incidence of type 2 diabetes in women (Swedish). FASEB J 2010;
24: 326–331.
68 Jerna˚s M, Palming J, Sjo¨holm K, Jennische E, Svensson PA,
Gabrielsson BG et al. Separation of human adipocytes by size:
hypertrophic fat cells display distinct gene expression. FASEB J
2006; 20: 1540–1542.
69 Drolet R, Richard C, Sniderman AD, Mailloux J, Fortier M, Huot C
et al. Hypertrophy and hyperplasia of abdominal adipose tissues
in women. Int J Obes 2008; 32: 283–291.
70 Tchoukalova YD, Koutsari C, Karpyak MV, Votruba SB, Wendland
E, Jensen MD. Subcutaneous adipocyte size and body fat
distribution. Am J Clin Nutr 2008; 87: 56–63.
71 Spalding KL, Arner E, Westermark PO, Bernard S, Buchholz BA,
Bergmann O et al. Dynamics of fat cell turnover in humans.
Nature 2008; 453: 783–787.
72 Arner E, Westermark PO, Spalding KL, Britton T, Ryde´n M, Frise´n J
et al. Adipocyte turnover: relevance to human adipose tissue
morphology. Diabetes 2010; 59: 105–109.
73 Gill T. Epidemiology and health impact of obesity: an Asia Pacific
perspective. Asia Pac J Clin Nutr 2006; 15 (Suppl): 3–14.
74 Kurian AK, Cardarelli KM. Racial and ethnic differences in
cardiovascular disease risk factors: a systematic review. Ethn Dis
2007; 17: 143–152.
75 Raji A, Seely EW, Arky RA, Simonson DC. Body fat distribution
and insulin resistance in healthy Asian Indians and Caucasians.
J Clin Endocrinol Metab 2001; 86: 5366–5371.
76 Chowdhury B, Lantz H, Sjostrom L. Computed tomography-
determined body composition in relation to cardiovascular risk
factors in Indian and matched Swedish males. Metabolism 1996;
45: 634–644.
13
ht
tp
://
do
c.
re
ro
.c
h
77 Park YW, Allison DB, Heymsfield SB, Gallagher D. Larger amounts
of visceral adipose tissue in Asian Americans. Obes Res 2001; 9:
381–387.
78 Hill JO, Sidney S, Lewis CE, Tolan K, Scherzinger AL, Stamm ER.
Racial differences in amounts of visceral adipose tissue in young
adults: the CARDIA (Coronary Artery Risk Development in Young
Adults) study. Am J Clin Nutr 1999; 69: 381–387.
79 Hoffman DJ, Wang Z, Gallagher D, Heymsfield SB. Comparison of
visceral adipose tissue mass in adult African Americans and
whites. Obes Res 2005; 13: 66–74.
80 Despres JP, Couillard C, Gagnon J, Bergeron J, Leon AS, Rao DC
et al. Race, visceral adipose tissue, plasma lipids, and lipoprotein
lipase activity in men and women: the Health, Risk Factors,
Exercise Training, and Genetics (HERITAGE) family study.
Arterioscler Thromb Vasc Biol 2000; 20: 1932–1938.
81 Lovejoy JC, Smith SR, Rood JC. Comparison of regional fat
distribution and health risk factors in middle-aged white and
African American women: the Healthy Transitions Study. Obes
Res 2001; 9: 10–16.
82 Misra A, Khurana L. Obesity-related non-communicable diseases:
South Asians vs White Caucasians. Int J Obes (Lond) 2010. (e-pub
ahead of print).
83 Lear SA, Humphries KH, Kohli S, Chockalingam A, Frohlich JJ,
Birmingham CL. Visceral adipose tissue accumulation differs
according to ethnic background: result of the Multicultural
Community Health Assessment Trial (M-CHAT). Am J Clin Nutr
2007; 86: 353–359.
84 Gautier JF, Milner MR, Elam E, Chen K, Ravussin E, Pratley RE.
Visceral adipose tissue is not increased in Pima Indians compared
with equally obese Caucasians and is not related to insulin action
or secretion. Diabetologia 1999; 42: 28–34.
85 Goel K, Misra A, Vikram NK, Poddar P, Gupta N. Subcutaneous
abdominal adipose tissue is associated with the metabolic
syndrome in Asian Indians independent of intra-abdominal and
total body fat. Heart 2010; 96: 579–583.
86 Misra A, Khurana L. Obesity and the metabolic syndrome in
developing countries. J Clin Endocrinol Metab 2008; 93 (Suppl 1):
S9–S30.
87 Kohli S, Sniderman AD, Tchernof A, Lear SA. Ethnic-Specific
Differences in Abdominal Subcutaneous Adipose Tissue Com-
partments. Obesity (Silver Spring 2010. (e-pub ahead of print).
88 Sniderman AD, Bhopal R, Prabhakaran D, Sarrafzadegan N,
Tchernof A. Why might South Asians be so susceptible to central
obesity and its atherogenic consequences? The adipose tissue
overflow hypothesis. Int J Epidemiol 2007; 36: 220–225.
89 Yajnik CS, Lubree HG, Rege SS, Naik SS, Deshpande JA,
Deshpande SS et al. Adiposity and hyperinsulinemia in
Indians are present at birth. J Clin Endocrinol Metab 2002; 87:
5575–5580.
90 Katzmarzyk PT, Bray GA, Greenway FL, Johnson WD, Newton Jr
RL, Ravussin E et al. Racial differences in abdominal depot-
specific adiposity in white and African American adults. Am J Clin
Nutr 2010; 91: 7–15.
91 Liska D, Dufour S, Zern TL, Taksali S, Calı´ AM, Dziura J et al.
Interethnic differences in muscle, liver and abdominal fat
partitioning in obese adolescents. PLoS One 2007; 2: e569.
92 Smith LM, Yao-Borengasser A, Starks T, Tripputi M, Kern PA,
Rasouli N. Insulin resistance in African-American and Caucasian
women: differences in lipotoxicity, adipokines, and gene expres-
sion in adipose tissue and muscle. J Clin Endocrinol Metab 2010;
95: 4441–4448.
93 Guerrero R, Vega GL, Grundy SM, Browning JD. Ethnic
differences in hepatic steatosis: an insulin resistance paradox?
Hepatology 2009; 49: 791–801.
94 Lawrence JC, Newcomer BR, Buchthal SD, Sirikul B, Oster RA,
Hunter GR et al. Relationship of intramyocellular lipid to insulin
sensitivity may differ with ethnicity in healthy girls and women.
Obesity (Silver Spring 2010. (e-pub ahead of print).
95 Yim JE, Heshka S, Albu JB, Heymsfield S, Gallagher D. Femoral-
gluteal subcutaneous and intermuscular adipose tissues have
independent and opposing relationships with CVD risk. J Appl
Physiol 2008; 104: 700–707.
96 Petersen KF, Dufour S, Feng J, Befroy D, Dziura J, Dalla Man C
et al. Increased prevalence of insulin resistance and nonalcoholic
fatty liver disease in Asian-Indian men. Proc Natl Acad Sci (USA)
2006; 103: 18273–18277.
14
ht
tp
://
do
c.
re
ro
.c
h
